Vaxart, Inc.
VXRT· OTC
Filed Aug 3, 2011 · 10-Q · 39 days after period end · 0001193125-11-208394
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $3.74M | $4.85M |
| Net Income | -$4.60M | -$3.41M |
| EPS Diluted | -$0.11 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Jun 25, 2011 · filed Aug 3, 2011 · 39 d after period end